Substance Use Disorder

A dose response is observed with the highest dose of the drug and mitigating withdrawal symptoms for patients with cannabis use disorder.

The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.

AMA released its 2024 Overdose Epidemic Report and presented key findings from the past year.

The FDA has mandated that companies participating in the Opioid Analgesic Risk Evaluation and Mitigation Strategy program provide pre-paid mail-back envelopes for unused or expired opioid medications.

As health care systems and the current syndemic continue to evolve, pharmacies are poised to play a crucial role in improving public health.

Research presented at ACCP 2024 found that addiction medicine consult services could help increase medication for opioid use disorder initiation.

In posters presented at the Heart Failure Society of America 2024 Annual Meeting, researchers assessed how substance use disorders impact cardiovascular outcomes.

Sara T. Thomason discuses the impact of stigma on pharmacists who are dealing with substance use disorder, the importance of mental health care, and how schools support pharmacy students dealing with addiction.

Investigators used electronic health record data to compare outcomes of semaglutide vs other antidiabetic medications.

Pharmacy professionals are at an increased risk of substance abuse due to many factors, but long-term recovery can be achieved with the help of specialized recovery networks.

Higher doses of buprenorphine may also be more effective against the increasing prevalence of fentanyl in the opioid crisis.

Independent pharmacists, health care providers, community leaders, and law enforcement must all work together to address the fentanyl epidemic.

Community pharmacies in counties with high racialized economic segregation had higher odds of restricting buprenorphine.

Nalmefene injection is an opioid receptor antagonist and comes in a single-dose, pre-filled auto-injector that delivers 1.5 mg of the medication per actuation.

The study’s mixed findings on telehealth for opioid use disorder (OUD) treatment suggest a need for more individualized approaches to care.

A study found that cannabis use increased the risk of hospitalization and intensive care unit admission following a COVID-19 diagnosis.

Check out these top featured stories from Drug Topics in June 2024.

A posted presented at ASHP 2024 examined if improved access to methadone could decrease hospital length of stay and readmission rates.

As the opioid crisis and injection drug use continue, pharmacists can look to previous outbreaks to guide their responses to the HIV–injection drug use syndemic.

The new task force highlights a stronger government focus on curbing the risks of e-cigarettes for young people, especially after sustained calls for stricter action on the public health issue by lawmakers and the public.

Overdose deaths have decreased for the first time since 2018, but naloxone remains an important tool in fighting the opioid epidemic.

Research presented at ENDO 2024 found that environmental stress increased the likelihood of earlier alcohol, nicotine and cannabis use in females and traumatic events increased the likelihood in males.

According to a survey, 18.9% of respondents said that the person they knew who died of a drug overdose was a family member or close friend.

Check out these top featured stories from Drug Topics in May 2024.

Savannah Roberts Clary, PharmD, BCPS, CPGx, a clinical pharmacist with Aegis Sciences Corporation, discusses what tianeptine is and how pharmacists can help warn the public about its potential hazards.